Écrit par WILEY | 14 Juillet 2017

Hoboken, NJ —July 13, 2017 — John Wiley and Sons, Inc. (NYSE:JWa) (NYSE:JWb), is pleased to announce a new partnership with the International AIDS Society (IAS) to publish their fully open access journal, Journal of the International AIDS Society (JIAS).  JIAS is well-established with an Impact Factor of 6.296, and all articles in the journal are open access and free to view, download...

Écrit par GlobalData | 14 Juillet 2017

The acute myeloid leukemia (AML) market across the seven major countries (7MM) of the US, France, Germany, Italy, Spain, the UK, and Japan, will more than triple from $406 million in 2016 to over $1.5 billion by 2026, representing a compound annual growth rate of 14%, according to research and consulting firm GlobalData.

The company’s latest report states that major drivers of the AML...

Écrit par NIHR | 14 Juillet 2017

University of Warwick researchers are to improve the lives of India’s millions of psychosis sufferers.



The National Institute of Health Research’s (NIHR) Global Health Research Unit has awarded the University’s Warwick Medical School £1.5 million (almost USD 2 million) to work with this highly vulnerable and disadvantaged group. The award will be used to improve their health...

Écrit par Guerbet | 10 Juillet 2017

Villepinte, le 10 juillet 2017 (7h00) - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l'imagerie médicale, annonce aujourd'hui qu'il va cesser progressivement la commercialisation de deux produits : Hexabrix® (ioxaglate de meglumine et de sodium) et Optimark® (gadoversétamide).




Suite à l'acquisition de l'activité de produits de contraste...